An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors

NCT03154437 · clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Genentech, Inc.